Intellikine
Discovers and develops small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation, and autoimmune disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD479m (Public information from Dec 2011)
San Diego California (HQ)
Authorizing premium user...